Roy Noy - Concepedia

Author

Roy Noy

Technion – Israel Institute of Technology

Also Known As

R. J. Noy, R.J. Noy, Roy Noy

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

Technion – Israel Institute of Technology Queen's Medical Centre MRC Centre for Reproductive Health University of Edinburgh Albert Einstein College of Medicine

About

Roy Noy is an author at Technion – Israel Institute of Technology specializing in medicine, immunology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	510
2	Cell Biology	5	5	118
3	Engineering	1	1	16
4	Biochemistry	1	1	16
5	Biomolecular Engineering	1	1	16

Roy Noy

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages Takanori Kitamura, Bin‐Zhi Qian, Daniel Soong, The Journal of Experimental Medicine	2015	645
Tumor-Associated Macrophages: From Mechanisms to Therapy Roy Noy, Jeffrey W. Pollard Immunity InflammationTumor-associated MacrophagesImmunologyMedicineTumor Microenvironment	2014	269
Isolation of Mouse and Human Tumor-Associated Macrophages Luca Cassetta, Roy Noy, Agnieszka Swierczak, Advances in experimental medicine and biology ImmunologyPathologyMedicineHuman Tumor-associated MacrophagesTumor Microenvironment	2016	81
Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts<i>in vivo</i> Avital Lev, Roy Noy, Kfir Oved, Proceedings of the National Academy of Sciences ImmunologyAntigen ProcessingImmunotherapeuticsImmunotherapyCancer Biology	2004	37
chFRP5-ZZ-PE38, a large IgG-toxin immunoconjugate outperforms the corresponding smaller FRP5(Fv)-ETA immunotoxin in eradicating ErbB2-expressing tumor xenografts Yariv Mazor, Roy Noy, Winfried S. Wels, Cancer Letters Signaling PathwayErbb2-expressing Tumor XenograftsLarge Igg-toxin ImmunoconjugateCorresponding Smaller Frp5Immunology	2007	28
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages Takanori Kitamura, Bin‐Zhi Qian, Daniel Soong, The Journal of Cell Biology InflammationCytokineBreast OncologyMetastasis-associated MacrophagesMedicine	2015	22
Antibody-mediated targeting of human single-chain class I MHC with covalently linked peptides induces efficient killing of tumor cells by tumor or viral-specific cytotoxic T lymphocytes Kfir Oved, Avital Lev, Roy Noy, Cancer Immunology Immunotherapy Cancer ImmunosurveillanceImmunologyTumor ImmunityTherapeutic VaccineTumor Cells	2005	16
Oligosaccharide Component Composition and Storage Properties of Commercial Low DE Maltodextrins and Their Further Modification by Enzymatic Treatment John F. Kennedy, Roy Noy, J. A. Stead, Starch - Stärke EngineeringGlycobiologyPolysaccharideMaltodextrin MaterialsMixed Biopolymers	1985	16
A Novel Postpriming Regulatory Check Point of Effector/Memory T Cells Dictated through Antigen Density Threshold-Dependent Anergy Kfir Oved, Omer Ziv, Jasmine Jacob‐Hirsch, The Journal of Immunology T-regulatory CellImmunologyImmune RegulationSelf ReactivityImmunologic Mechanism	2007	15
Predicting and controlling the reactivity of immune cell populations against cancer Kfir Oved, Eran Eden, Martin Akerman, Molecular Systems Biology Immune EvasionSystems BiologyCancer ImmunosurveillanceImmunologyImmune Checkpoint Inhibitor	2009	15

Page 1